nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—cartilage tissue—rheumatoid arthritis	0.0269	0.183	CbGeAlD
Amlexanox—IL3—connective tissue—rheumatoid arthritis	0.0229	0.156	CbGeAlD
Amlexanox—IL3—lymphoid tissue—rheumatoid arthritis	0.0167	0.114	CbGeAlD
Amlexanox—S100A13—connective tissue—rheumatoid arthritis	0.0109	0.0741	CbGeAlD
Amlexanox—S100A12—connective tissue—rheumatoid arthritis	0.0107	0.0731	CbGeAlD
Amlexanox—S100A13—digestive system—rheumatoid arthritis	0.00785	0.0535	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—rheumatoid arthritis	0.00784	0.0534	CbGeAlD
Amlexanox—S100A12—digestive system—rheumatoid arthritis	0.00774	0.0528	CbGeAlD
Amlexanox—FGF1—connective tissue—rheumatoid arthritis	0.00669	0.0456	CbGeAlD
Amlexanox—Aphthous stomatitis—Leflunomide—rheumatoid arthritis	0.00663	0.0739	CcSEcCtD
Amlexanox—Mouth ulceration—Penicillamine—rheumatoid arthritis	0.00572	0.0638	CcSEcCtD
Amlexanox—PDE4D—tendon—rheumatoid arthritis	0.00492	0.0335	CbGeAlD
Amlexanox—FGF1—lymphoid tissue—rheumatoid arthritis	0.00489	0.0334	CbGeAlD
Amlexanox—FGF1—digestive system—rheumatoid arthritis	0.00483	0.0329	CbGeAlD
Amlexanox—Throat sore—Leflunomide—rheumatoid arthritis	0.00431	0.0481	CcSEcCtD
Amlexanox—PDE4B—parotid gland—rheumatoid arthritis	0.00429	0.0292	CbGeAlD
Amlexanox—Oropharyngeal discomfort—Leflunomide—rheumatoid arthritis	0.00427	0.0477	CcSEcCtD
Amlexanox—PDE4B—saliva-secreting gland—rheumatoid arthritis	0.00411	0.028	CbGeAlD
Amlexanox—Stomatitis—Auranofin—rheumatoid arthritis	0.00373	0.0416	CcSEcCtD
Amlexanox—Stomatitis—Penicillamine—rheumatoid arthritis	0.00345	0.0385	CcSEcCtD
Amlexanox—Oropharyngeal pain—Leflunomide—rheumatoid arthritis	0.00342	0.0381	CcSEcCtD
Amlexanox—Mouth ulceration—Leflunomide—rheumatoid arthritis	0.00281	0.0313	CcSEcCtD
Amlexanox—Throat sore—Triamcinolone—rheumatoid arthritis	0.00278	0.0311	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Triamcinolone—rheumatoid arthritis	0.00276	0.0308	CcSEcCtD
Amlexanox—PDE4B—lymphoid tissue—rheumatoid arthritis	0.00276	0.0188	CbGeAlD
Amlexanox—PDE4B—tendon—rheumatoid arthritis	0.00259	0.0177	CbGeAlD
Amlexanox—Pain—Ergocalciferol—rheumatoid arthritis	0.00256	0.0286	CcSEcCtD
Amlexanox—Oropharyngeal pain—Triamcinolone—rheumatoid arthritis	0.00221	0.0246	CcSEcCtD
Amlexanox—Liver function test abnormal—Leflunomide—rheumatoid arthritis	0.00208	0.0232	CcSEcCtD
Amlexanox—Nausea—Ergocalciferol—rheumatoid arthritis	0.00178	0.0199	CcSEcCtD
Amlexanox—Stomatitis—Leflunomide—rheumatoid arthritis	0.00169	0.0189	CcSEcCtD
Amlexanox—Nausea—Auranofin—rheumatoid arthritis	0.00145	0.0162	CcSEcCtD
Amlexanox—Nausea—Penicillamine—rheumatoid arthritis	0.00134	0.0149	CcSEcCtD
Amlexanox—Stomatitis—Cyclosporine—rheumatoid arthritis	0.00131	0.0146	CcSEcCtD
Amlexanox—Mouth ulceration—Methotrexate—rheumatoid arthritis	0.0012	0.0134	CcSEcCtD
Amlexanox—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.00109	0.0121	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.00101	0.0113	CcSEcCtD
Amlexanox—Paraesthesia—Leflunomide—rheumatoid arthritis	0.000996	0.0111	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000957	0.0107	CcSEcCtD
Amlexanox—Pain—Leflunomide—rheumatoid arthritis	0.000948	0.0106	CcSEcCtD
Amlexanox—Liver function test abnormal—Methotrexate—rheumatoid arthritis	0.000888	0.00991	CcSEcCtD
Amlexanox—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000839	0.00936	CcSEcCtD
Amlexanox—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.000768	0.00857	CcSEcCtD
Amlexanox—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000746	0.00832	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000739	0.00824	CcSEcCtD
Amlexanox—Headache—Azathioprine—rheumatoid arthritis	0.000736	0.00821	CcSEcCtD
Amlexanox—Pain—Cyclosporine—rheumatoid arthritis	0.000732	0.00816	CcSEcCtD
Amlexanox—Stomatitis—Methotrexate—rheumatoid arthritis	0.000723	0.00806	CcSEcCtD
Amlexanox—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000701	0.00782	CcSEcCtD
Amlexanox—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000699	0.0078	CcSEcCtD
Amlexanox—Nausea—Azathioprine—rheumatoid arthritis	0.000697	0.00778	CcSEcCtD
Amlexanox—Headache—Leflunomide—rheumatoid arthritis	0.000695	0.00775	CcSEcCtD
Amlexanox—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000683	0.00762	CcSEcCtD
Amlexanox—Pain—Prednisolone—rheumatoid arthritis	0.000666	0.00743	CcSEcCtD
Amlexanox—Nausea—Leflunomide—rheumatoid arthritis	0.000659	0.00735	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000657	0.00732	CcSEcCtD
Amlexanox—Pain—Hydrocortisone—rheumatoid arthritis	0.00065	0.00725	CcSEcCtD
Amlexanox—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000643	0.00717	CcSEcCtD
Amlexanox—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000642	0.00716	CcSEcCtD
Amlexanox—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000637	0.00711	CcSEcCtD
Amlexanox—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000637	0.00711	CcSEcCtD
Amlexanox—Pain—Triamcinolone—rheumatoid arthritis	0.000612	0.00683	CcSEcCtD
Amlexanox—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000584	0.00651	CcSEcCtD
Amlexanox—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000584	0.00651	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000561	0.00626	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000561	0.00626	CcSEcCtD
Amlexanox—Pain—Betamethasone—rheumatoid arthritis	0.000556	0.0062	CcSEcCtD
Amlexanox—Pain—Dexamethasone—rheumatoid arthritis	0.000556	0.0062	CcSEcCtD
Amlexanox—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000555	0.00619	CcSEcCtD
Amlexanox—Headache—Cyclosporine—rheumatoid arthritis	0.000536	0.00598	CcSEcCtD
Amlexanox—Nausea—Cyclosporine—rheumatoid arthritis	0.000508	0.00567	CcSEcCtD
Amlexanox—Paraesthesia—Prednisone—rheumatoid arthritis	0.000508	0.00567	CcSEcCtD
Amlexanox—Headache—Prednisolone—rheumatoid arthritis	0.000488	0.00544	CcSEcCtD
Amlexanox—Headache—Hydrocortisone—rheumatoid arthritis	0.000476	0.00531	CcSEcCtD
Amlexanox—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000464	0.00517	CcSEcCtD
Amlexanox—Nausea—Prednisolone—rheumatoid arthritis	0.000463	0.00516	CcSEcCtD
Amlexanox—Nausea—Hydrocortisone—rheumatoid arthritis	0.000452	0.00504	CcSEcCtD
Amlexanox—Headache—Triamcinolone—rheumatoid arthritis	0.000449	0.005	CcSEcCtD
Amlexanox—Headache—Methylprednisolone—rheumatoid arthritis	0.000448	0.00499	CcSEcCtD
Amlexanox—Nausea—Triamcinolone—rheumatoid arthritis	0.000425	0.00474	CcSEcCtD
Amlexanox—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000425	0.00474	CcSEcCtD
Amlexanox—Nausea—Methylprednisolone—rheumatoid arthritis	0.000424	0.00473	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000408	0.00455	CcSEcCtD
Amlexanox—Headache—Betamethasone—rheumatoid arthritis	0.000407	0.00454	CcSEcCtD
Amlexanox—Headache—Dexamethasone—rheumatoid arthritis	0.000407	0.00454	CcSEcCtD
Amlexanox—Pain—Methotrexate—rheumatoid arthritis	0.000404	0.00451	CcSEcCtD
Amlexanox—Nausea—Betamethasone—rheumatoid arthritis	0.000386	0.00431	CcSEcCtD
Amlexanox—Nausea—Dexamethasone—rheumatoid arthritis	0.000386	0.00431	CcSEcCtD
Amlexanox—Headache—Prednisone—rheumatoid arthritis	0.000355	0.00395	CcSEcCtD
Amlexanox—Nausea—Prednisone—rheumatoid arthritis	0.000336	0.00375	CcSEcCtD
Amlexanox—Headache—Methotrexate—rheumatoid arthritis	0.000296	0.0033	CcSEcCtD
Amlexanox—Nausea—Methotrexate—rheumatoid arthritis	0.000281	0.00313	CcSEcCtD
Amlexanox—PDE4C—Signaling Pathways—MMP3—rheumatoid arthritis	6.94e-05	9.09e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TYK2—rheumatoid arthritis	6.94e-05	9.09e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NCF1—rheumatoid arthritis	6.93e-05	9.08e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-B—rheumatoid arthritis	6.87e-05	8.99e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.84e-05	8.96e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—POMC—rheumatoid arthritis	6.8e-05	8.9e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD4—rheumatoid arthritis	6.76e-05	8.85e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.73e-05	8.82e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—STAT1—rheumatoid arthritis	6.72e-05	8.8e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTK2—rheumatoid arthritis	6.68e-05	8.75e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—rheumatoid arthritis	6.67e-05	8.74e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CD28—rheumatoid arthritis	6.67e-05	8.73e-05	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—rheumatoid arthritis	6.66e-05	8.72e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.66e-05	8.72e-05	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.65e-05	8.71e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL2—rheumatoid arthritis	6.65e-05	8.71e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SYK—rheumatoid arthritis	6.63e-05	8.69e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6R—rheumatoid arthritis	6.63e-05	8.68e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL10—rheumatoid arthritis	6.63e-05	8.68e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1B—rheumatoid arthritis	6.62e-05	8.67e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.6e-05	8.65e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL12—rheumatoid arthritis	6.6e-05	8.65e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2—rheumatoid arthritis	6.6e-05	8.64e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—POMC—rheumatoid arthritis	6.59e-05	8.63e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL5—rheumatoid arthritis	6.55e-05	8.58e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6ST—rheumatoid arthritis	6.55e-05	8.57e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.53e-05	8.55e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.51e-05	8.53e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—POMC—rheumatoid arthritis	6.47e-05	8.47e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CSF2—rheumatoid arthritis	6.45e-05	8.45e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2RA—rheumatoid arthritis	6.43e-05	8.42e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—STAT1—rheumatoid arthritis	6.4e-05	8.38e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TYK2—rheumatoid arthritis	6.4e-05	8.38e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C3—rheumatoid arthritis	6.38e-05	8.35e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-A—rheumatoid arthritis	6.36e-05	8.33e-05	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2—rheumatoid arthritis	6.36e-05	8.33e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL2—rheumatoid arthritis	6.33e-05	8.29e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6R—rheumatoid arthritis	6.31e-05	8.27e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL10—rheumatoid arthritis	6.31e-05	8.26e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOS3—rheumatoid arthritis	6.28e-05	8.22e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.28e-05	8.22e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—NFKB1—rheumatoid arthritis	6.18e-05	8.09e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.16e-05	8.06e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.16e-05	8.06e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL12—rheumatoid arthritis	6.16e-05	8.06e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SYK—rheumatoid arthritis	6.14e-05	8.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.09e-05	7.97e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAPK8—rheumatoid arthritis	6.07e-05	7.95e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SPP1—rheumatoid arthritis	6.07e-05	7.95e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—rheumatoid arthritis	6.07e-05	7.95e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—NFKB1—rheumatoid arthritis	6.06e-05	7.94e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP3—rheumatoid arthritis	6.04e-05	7.91e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.04e-05	7.91e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TYK2—rheumatoid arthritis	6.04e-05	7.91e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CCR5—rheumatoid arthritis	6.03e-05	7.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.03e-05	7.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—POMC—rheumatoid arthritis	5.99e-05	7.84e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK8—rheumatoid arthritis	5.96e-05	7.8e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—STAT1—rheumatoid arthritis	5.92e-05	7.75e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCR5—rheumatoid arthritis	5.9e-05	7.73e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTHFR—rheumatoid arthritis	5.89e-05	7.71e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—HLA-A—rheumatoid arthritis	5.87e-05	7.69e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL2—rheumatoid arthritis	5.86e-05	7.67e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6R—rheumatoid arthritis	5.84e-05	7.65e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL10—rheumatoid arthritis	5.84e-05	7.64e-05	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—NFKB1—rheumatoid arthritis	5.82e-05	7.62e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2RA—rheumatoid arthritis	5.82e-05	7.62e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTK2—rheumatoid arthritis	5.82e-05	7.62e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TLR4—rheumatoid arthritis	5.82e-05	7.62e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HLA-DRB1—rheumatoid arthritis	5.81e-05	7.61e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.79e-05	7.58e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2—rheumatoid arthritis	5.77e-05	7.56e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—C3—rheumatoid arthritis	5.77e-05	7.55e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP3—rheumatoid arthritis	5.75e-05	7.53e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TYK2—rheumatoid arthritis	5.75e-05	7.53e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.74e-05	7.52e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SYK—rheumatoid arthritis	5.72e-05	7.5e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL5—rheumatoid arthritis	5.7e-05	7.47e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.62e-05	7.36e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CSF2—rheumatoid arthritis	5.62e-05	7.36e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6ST—rheumatoid arthritis	5.58e-05	7.3e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ICAM1—rheumatoid arthritis	5.58e-05	7.3e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CXCL8—rheumatoid arthritis	5.57e-05	7.29e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTK2—rheumatoid arthritis	5.54e-05	7.25e-05	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2—rheumatoid arthritis	5.54e-05	7.25e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—STAT1—rheumatoid arthritis	5.52e-05	7.23e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.51e-05	7.22e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.44e-05	7.13e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL5—rheumatoid arthritis	5.43e-05	7.11e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—LEP—rheumatoid arthritis	5.37e-05	7.03e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD80—rheumatoid arthritis	5.37e-05	7.03e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CSF2—rheumatoid arthritis	5.35e-05	7e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2—rheumatoid arthritis	5.32e-05	6.97e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP3—rheumatoid arthritis	5.32e-05	6.97e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TYK2—rheumatoid arthritis	5.32e-05	6.97e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—rheumatoid arthritis	5.3e-05	6.94e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SPP1—rheumatoid arthritis	5.28e-05	6.92e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2—rheumatoid arthritis	5.27e-05	6.9e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.26e-05	6.89e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6ST—rheumatoid arthritis	5.15e-05	6.74e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCR5—rheumatoid arthritis	5.14e-05	6.73e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTK2—rheumatoid arthritis	5.12e-05	6.71e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS2—rheumatoid arthritis	5.11e-05	6.69e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	5.1e-05	6.68e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FN1—rheumatoid arthritis	5.06e-05	6.63e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2RA—rheumatoid arthritis	5.06e-05	6.63e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6ST—rheumatoid arthritis	5.04e-05	6.61e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—rheumatoid arthritis	5.04e-05	6.6e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SPP1—rheumatoid arthritis	5.03e-05	6.58e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2—rheumatoid arthritis	5.03e-05	6.58e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL5—rheumatoid arthritis	5.02e-05	6.58e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—C3—rheumatoid arthritis	5.02e-05	6.58e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.01e-05	6.56e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NFKB1—rheumatoid arthritis	4.98e-05	6.53e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6R—rheumatoid arthritis	4.98e-05	6.52e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP3—rheumatoid arthritis	4.96e-05	6.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD80—rheumatoid arthritis	4.96e-05	6.49e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CSF2—rheumatoid arthritis	4.95e-05	6.48e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK8—rheumatoid arthritis	4.9e-05	6.42e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCR5—rheumatoid arthritis	4.89e-05	6.4e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2—rheumatoid arthritis	4.87e-05	6.38e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CD80—rheumatoid arthritis	4.86e-05	6.36e-05	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—rheumatoid arthritis	4.84e-05	6.34e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2RA—rheumatoid arthritis	4.82e-05	6.31e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2—rheumatoid arthritis	4.78e-05	6.26e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—C3—rheumatoid arthritis	4.78e-05	6.26e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTK2—rheumatoid arthritis	4.78e-05	6.26e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL5—rheumatoid arthritis	4.68e-05	6.13e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LEP—rheumatoid arthritis	4.68e-05	6.12e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SPP1—rheumatoid arthritis	4.65e-05	6.09e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CXCL8—rheumatoid arthritis	4.63e-05	6.07e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CSF2—rheumatoid arthritis	4.61e-05	6.04e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—rheumatoid arthritis	4.61e-05	6.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6R—rheumatoid arthritis	4.59e-05	6.02e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TYK2—rheumatoid arthritis	4.53e-05	5.93e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCR5—rheumatoid arthritis	4.53e-05	5.93e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—rheumatoid arthritis	4.52e-05	5.92e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL2—rheumatoid arthritis	4.51e-05	5.91e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6R—rheumatoid arthritis	4.5e-05	5.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2RA—rheumatoid arthritis	4.46e-05	5.84e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LEP—rheumatoid arthritis	4.45e-05	5.83e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2—rheumatoid arthritis	4.43e-05	5.8e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—C3—rheumatoid arthritis	4.42e-05	5.79e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FN1—rheumatoid arthritis	4.41e-05	5.77e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6ST—rheumatoid arthritis	4.39e-05	5.75e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SPP1—rheumatoid arthritis	4.34e-05	5.68e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IFNG—rheumatoid arthritis	4.24e-05	5.56e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CD80—rheumatoid arthritis	4.23e-05	5.53e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCR5—rheumatoid arthritis	4.22e-05	5.53e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FN1—rheumatoid arthritis	4.2e-05	5.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TYK2—rheumatoid arthritis	4.18e-05	5.48e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.18e-05	5.47e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2RA—rheumatoid arthritis	4.16e-05	5.45e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—rheumatoid arthritis	4.15e-05	5.44e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—C3—rheumatoid arthritis	4.12e-05	5.4e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LEP—rheumatoid arthritis	4.12e-05	5.39e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—rheumatoid arthritis	4.11e-05	5.38e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TYK2—rheumatoid arthritis	4.1e-05	5.37e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—rheumatoid arthritis	4.1e-05	5.37e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—rheumatoid arthritis	4.02e-05	5.27e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CD80—rheumatoid arthritis	4.02e-05	5.27e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—rheumatoid arthritis	4.02e-05	5.26e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL2—rheumatoid arthritis	3.93e-05	5.15e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6R—rheumatoid arthritis	3.92e-05	5.13e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FN1—rheumatoid arthritis	3.88e-05	5.08e-05	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—rheumatoid arthritis	3.88e-05	5.08e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6ST—rheumatoid arthritis	3.87e-05	5.06e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LEP—rheumatoid arthritis	3.84e-05	5.03e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—rheumatoid arthritis	3.82e-05	5.01e-05	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—rheumatoid arthritis	3.81e-05	4.98e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1B—rheumatoid arthritis	3.79e-05	4.96e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—rheumatoid arthritis	3.78e-05	4.96e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—rheumatoid arthritis	3.77e-05	4.94e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—rheumatoid arthritis	3.76e-05	4.92e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL2—rheumatoid arthritis	3.74e-05	4.9e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6R—rheumatoid arthritis	3.73e-05	4.88e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CD80—rheumatoid arthritis	3.72e-05	4.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FN1—rheumatoid arthritis	3.62e-05	4.74e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.61e-05	4.72e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CXCL8—rheumatoid arthritis	3.57e-05	4.67e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TYK2—rheumatoid arthritis	3.57e-05	4.67e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—rheumatoid arthritis	3.54e-05	4.63e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—NFKB1—rheumatoid arthritis	3.53e-05	4.62e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—rheumatoid arthritis	3.5e-05	4.59e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK8—rheumatoid arthritis	3.47e-05	4.55e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CD80—rheumatoid arthritis	3.47e-05	4.55e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL2—rheumatoid arthritis	3.46e-05	4.53e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6R—rheumatoid arthritis	3.45e-05	4.52e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—rheumatoid arthritis	3.42e-05	4.48e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—rheumatoid arthritis	3.41e-05	4.47e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TYK2—rheumatoid arthritis	3.4e-05	4.45e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—rheumatoid arthritis	3.39e-05	4.44e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—rheumatoid arthritis	3.33e-05	4.37e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—rheumatoid arthritis	3.3e-05	4.32e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—rheumatoid arthritis	3.23e-05	4.23e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL2—rheumatoid arthritis	3.23e-05	4.23e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6R—rheumatoid arthritis	3.22e-05	4.21e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NFKB1—rheumatoid arthritis	3.19e-05	4.18e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TYK2—rheumatoid arthritis	3.14e-05	4.12e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK8—rheumatoid arthritis	3.14e-05	4.11e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—rheumatoid arthritis	3.13e-05	4.1e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CXCL8—rheumatoid arthritis	3.11e-05	4.07e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—rheumatoid arthritis	3.08e-05	4.04e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—rheumatoid arthritis	2.97e-05	3.89e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CXCL8—rheumatoid arthritis	2.96e-05	3.87e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—rheumatoid arthritis	2.95e-05	3.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TYK2—rheumatoid arthritis	2.93e-05	3.84e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—rheumatoid arthritis	2.9e-05	3.8e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—rheumatoid arthritis	2.88e-05	3.77e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—rheumatoid arthritis	2.83e-05	3.7e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—rheumatoid arthritis	2.81e-05	3.68e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—rheumatoid arthritis	2.81e-05	3.68e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NFKB1—rheumatoid arthritis	2.78e-05	3.64e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CXCL8—rheumatoid arthritis	2.74e-05	3.58e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK8—rheumatoid arthritis	2.73e-05	3.58e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—rheumatoid arthritis	2.72e-05	3.56e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—rheumatoid arthritis	2.67e-05	3.5e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—rheumatoid arthritis	2.66e-05	3.48e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.65e-05	3.47e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—rheumatoid arthritis	2.62e-05	3.42e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—rheumatoid arthritis	2.6e-05	3.41e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.6e-05	3.41e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.55e-05	3.34e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—rheumatoid arthritis	2.52e-05	3.3e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—rheumatoid arthritis	2.47e-05	3.24e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NFKB1—rheumatoid arthritis	2.45e-05	3.21e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—rheumatoid arthritis	2.44e-05	3.19e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK8—rheumatoid arthritis	2.41e-05	3.15e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.4e-05	3.15e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—rheumatoid arthritis	2.32e-05	3.03e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—rheumatoid arthritis	2.31e-05	3.02e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.28e-05	2.99e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.24e-05	2.94e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—rheumatoid arthritis	2.22e-05	2.91e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—rheumatoid arthritis	2.22e-05	2.9e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.2e-05	2.89e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—rheumatoid arthritis	2.19e-05	2.87e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.07e-05	2.71e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—rheumatoid arthritis	2.05e-05	2.68e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—rheumatoid arthritis	2.04e-05	2.67e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—rheumatoid arthritis	2e-05	2.63e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—rheumatoid arthritis	1.91e-05	2.5e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.9e-05	2.49e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—rheumatoid arthritis	1.81e-05	2.38e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—rheumatoid arthritis	1.75e-05	2.29e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—rheumatoid arthritis	1.68e-05	2.2e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—rheumatoid arthritis	1.66e-05	2.18e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—rheumatoid arthritis	1.57e-05	2.05e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—rheumatoid arthritis	1.54e-05	2.01e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—rheumatoid arthritis	1.43e-05	1.88e-05	CbGpPWpGaD
